Collegium Pharmaceutical (COLL) Current Assets (2014 - 2026)

Collegium Pharmaceutical has reported Current Assets for 13 years, with the latest figure at $608.0 million in Q2 2026.

• On a quarterly basis, Current Assets rose 10.71% year-over-year to $608.0 million in Q2 2026; TTM through Jun 2026 was $608.0 million, a 10.71% increase from a year earlier, with the FY2025 full-year figure at $691.4 million, up 43.37% from the prior year.
• Current Assets was $608.0 million for Q2 2026 at Collegium Pharmaceutical, down from $745.7 million in the prior quarter.
• The five-year high for Current Assets was $745.7 million in Q1 2026, with the low at $363.6 million in Q1 2022.
• Average Current Assets over 5 years is $523.3 million, with a median of $532.3 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Current Assets decreased 17.37% in 2024, then surged 43.37% in 2025.
• Over 5 years, Current Assets stood at $420.0 million in 2022, then increased by 28.0% to $537.6 million in 2023, then declined by 10.29% to $482.3 million in 2024, then surged by 43.37% to $691.4 million in 2025, then fell by 12.06% to $608.0 million in 2026.
• The last three Current Assets figures came in at $608.0 million (Q2 2026), $745.7 million (Q1 2026), and $691.4 million (Q4 2025), per Business Quant data.